Prognostic factors in dogs with urinary bladder carcinoma

Journal of veterinary internal medicine / American College of Veterinary Internal Medicine

Volumn 14, Issue 5, 2000, Pages 486-490

  Rocha, Timothy A ^a   Mauldin, G Neal ^a   Patnaik, Amiya K ^a   Bergman, Philip J ^b  

^a ANIMAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLOOD CLOTTING FACTOR 8; CARBOPLATIN; CISPLATIN; DOXORUBICIN; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; MITOXANTRONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLADDER TUMOR; CARCINOMA; DOG; DOG DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; DOG DISEASES; DOGS; DOXORUBICIN; FACTOR VIII; FEMALE; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; MALE; MITOXANTRONE; P-GLYCOPROTEIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0034277451     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2000.tb02263.x     Document Type: Article

References (18)

1. 1 Chun R., Knapp DW, Widmer WR, et al. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983–1993). J Am Vet Med Assoc 1996 ; 209: 1588–1591.
2. 2 Moore AS, Cardona A., Shapiro W., et al. Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra: A retrospective study of 15 dogs. J Vet Intern Med 1990 ; 4: 148–152.
3. 3 Knapp DW, Richardson RC, Chan TCK, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994 ; 8: 273–278.
4. 4 Helfand SC, Hamilton TA, Hungerford LL, et al. Comparison of three treatments for transitional cell carcinoma of the bladder in the dog. J Am Anim Hosp Assoc 1994 ; 30: 270–275.
5. 5 Norris AM, Laing EJ, Valli VEO, et al. Canine bladder and urethral tumors: A retrospective study of 115 cases (1980–1985). J Vet Intern Med 1992 ; 6: 145–153.
6. 6 Walker M., Breider M. Intraoperative radiotherapy of canine bladder cancer. Vet Rad 1987 ; 200–204.
7. 7 Chun R., Knapp DW, Widmer WR, et al. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1997 ; 11: 279–283.
8. 8 Park J., Shinohara N., Liebert M., et al. P‐glycoprotein expression in bladder cancer. J Urol 1994 ; 151: 43–46.
9. 9 Thomas DJ, Birch PJ, Vickers J., et al. Glutathione‐s‐transferase π expression in transitional cell carcinoma of the bladder. Br J Urol 1993 ; 72: 740–743.
10. 10 Ahn H., Lee E., Kim K., et al. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines. J Urol 1994 ; 151: 263–267.
11. 11 Bochner BH, Cote RJ, Weidner N., et al. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995 ; 87: 1603–1612.
12. 12 Dickinson AJ, Fox SB, Persad RA, et al. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 1994 ; 74: 762–766.
13. 13 Shapiro W., Kitchell BE, Fossum TW, et al. Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs. J Am Vet Med Assoc 1988 ; 193: 1530–1533.
14. 14 Koss LG. Tumors of the urinary bladder. In: Atlas of Tumor Pathology. Second series, fascicle 11. Washington, DC: Armed Forces Institute of Pathology ; 1975: 11–37.
15. 15 Bergman PJ, Ogilvie GK, Powers BE. Monoclonal antibody C219 immunohistochemistry against P‐glycoprotein: Sequential analysis and predictive ability in dogs with lymphoma. J Vet Intern Med 1996 ; 10: 354–359.
16. 16 Burnie AG, Weaver AD. Urinary bladder neoplasia in the dog; a review of seventy cases. J Small Anim Pract 1983 ; 34: 129–143.
17. 17 Caywood DD, Osborne CA, Johnston GR. Neoplasms of the canine and feline urinary tracts. In: Kirk RW, ed. Current Veterinary Therapy VII. Philadelphia, PA: WB Saunders Co ; 1980: 1203–1212.
18. 18 Valli VE, Norris A., Jacobs RM, et al. Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival. J Comp Path 1995 ; 113: 113–130.